ACF Investors | Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

6,056 results for “ACF Investors”

Trials

View all 2769 →

Evaluation of Macular Edema After AcF Implant's Injection, 1 Month After the Last DXM Implant

34 participants · First posted Aug 18, 2023

SonoClear Acoustic Coupling Fluid (ACF) Mimicking Brain Tissue

45 participants · First posted Feb 2, 2021

Induction Chemotherapy With ACF Followed by Chemoradiation Therapy for Adv. Head & Neck Cancer

30 participants · First posted Mar 29, 2012

Drugs

View all 527 →

ACF-TEI

ACF516

AQF

Organizations

View all 46 →

Income Opportunity Realty Investors Inc

BANARAS HINDU UNIVERSITY

India

Polynoma LLC

United States

News

View all 2714 →

Monument Therapeutics Raises £850K to Advance Novel Schizophrenia Cognitive Treatment MT1988

Monument Therapeutics Reports Positive Phase I Results for Novel Schizophrenia Cognitive Treatment MT1988

Neurovalens Receives FDA De Novo Approval for PTSD Treatment Device Modius Spero

Page 1 of 606